Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy.
- DOI
- 10.1093/infdis/jiag320
- Published
- 2026-09-01
- Container
- J Infect Dis
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/infdis/jiag320,
title = {Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy.},
author = {Peng Q and Wong YC and Cheng WY and He Y and Xie C and Shi Y and Wang T and Du Y and Yang X and Wang Z and Wang H and Lu H and Chen Z and Jin X and ICVAX Phase I clinical trial study team.},
year = {2026},
journal = {J Infect Dis},
doi = {10.1093/infdis/jiag320},
url = {https://doi.org/10.1093/infdis/jiag320}
}RIS
TY - JOUR TI - Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy. AU - Peng Q AU - Wong YC AU - Cheng WY AU - He Y AU - Xie C AU - Shi Y AU - Wang T AU - Du Y AU - Yang X AU - Wang Z AU - Wang H AU - Lu H AU - Chen Z AU - Jin X AU - ICVAX Phase I clinical trial study team. PY - 2026 JO - J Infect Dis DO - 10.1093/infdis/jiag320 UR - https://doi.org/10.1093/infdis/jiag320 ER -
APA
Q, P., YC, W., WY, C., Y, H., C, X., Y, S., T, W., Y, D., X, Y., Z, W., H, W., H, L., Z, C., X, J., & team., I. P. I. C. T. S. (2026). Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy.. J Infect Dis. https://doi.org/10.1093/infdis/jiag320
Source records
- europe-pmc · retrieved 2026-09-26T22:37:15.166Z